VS

VCJ Staff

ReachLocal Files for $100 Million IPO

1 min read · 22 December 2009

LiveMocha Raises $8 Million

LiveMocha Inc., a Bellevue, Wash.-based provider of online language education, has raised $8 million in Series B funding. August Capital led the round, and was joined by return backer Maveron. The company previously raised nearly $6 million.

2 min read · 22 December 2009

MobGold Raises $12 Million

MobGold, a China-based provider of mobile advertising and mobile transaction solutions, has raised $12 million in Series B funding from Fast Global Investments.

3 min read · 22 December 2009

Ambit Biosciences Signs $390 Million Deal with Astellas

Ambit Biosciences and Astellas Pharma have agreed to jointly develop and commercialize FLT3 kinase inhibitors in oncology and non-oncology indications. Under the terms of the agreement, Ambit will receive an up-front cash payment of $40 million and will be eligible to receive pre-commercialization payments of up to $350 million. San Diego-based Ambit has raised over $100 million in VC funding, from MedImmune Ventures, OrbiMed Advisors, Radius Ventures, NovaQuest, Horizon Technology Finance, Perseus-Soros Biopharmaceutical Fund, Forward Ventures, Avalon Ventures, Roche Venture Fund, GIMV, Jov-CMDF and Genechem.

5 min read · 21 December 2009

SV Life Sciences Raising Fifth Fund

1 min read · 21 December 2009

CVS Caremark Ups Take in Generation Health

Generation Health Inc., a genetic benefit management company, has received a new investment from existing shareholder and strategic partner CVS Caremark. No financial terms were disclosed. Generation Health previously raised VC funding from Highland Capital Partners.

3 min read · 21 December 2009

3TS Cisco Backs SolveDirect

SolveDirect, a Vienna-based provider of provider of service management solutions, has raised an undisclosed amount of VC funding from the 3TS Cisco Growth Fund.

3 min read · 21 December 2009

Durata Therapeutics Launches, Buys Virucon Pharma

Durata Therapeutics Inc., an antibiotic development platform recently formed by five venture capital firms, has acquired Vicuron Pharmaceuticals, developer of an antibiotic drug candidate called dalbavancin, from Pfizer. No financial terms were disclosed. Durata's backers are New Leaf Venture Partners, Domain Associates, Aisling Capital, Sofinnova Ventures and Canaan Partners.

2 min read · 21 December 2009

BridgeCo Raises $7.5 Million

BridgeCo, an El Segundo, Calif.-based provider of digital home networking solutions, has raised $7.5 million in new VC funding. Earlybird Venture Capital and Christian Wenger co-led the round, and were joined by Brian Long (general partner with Atlantic Bridge). The company previously raised $59 million in private equity and debt funding, from Earlybird, Advent Venture Partners, Balderton Capital, Cipio Partners, Fidelity Ventures, Intel Capital and Wellington Partners.

3 min read · 21 December 2009

InnovationsKapital Backs Microdata Telecom

Microdata Telecom Innovation AB, a Stockholm, Sweden-based provider of radio solutions to OEMs and network operators has raised SEK10 million ($1.38m) in VC funding led by InnovationsKapital.

2 min read · 21 December 2009

Showing 6,141 to 6,150 of 12,104 results
1…614616…1000